The appointment of two experienced industry executives to major roles underlines this pharma's "commitment to investing in world-class talent and building capability to deliver on ambitious plans for the future," the Managing Director said.
New trial results could redefine how cancer patients are treated with two companies experiencing a massive boost in share price and market cap, with one pharma seeing its stock almost triple in value
Even with solid Phase 3 results showing a drug has a large benefit to patients, pharmas may hold off launching a drug in Australia over pricing
Members of a class action alleging the pharma knowingly sold ineffective medicine must register or risk missing out on a possible settlement
Just three of the 21 drugs named finalists for the prestigious 2026 Prix Galien USA Awards in the best pharmaceutical product category are subsidised in Australia
Despite concerns over strong challenges facing the pharmaceutical sector, the industry saw strong revenue growth in the second quarter of this year. Find out which companies are flying
In a year of declining revenue and a multi-billion dollar reported loss, the local giant had strong growth in many of its pharma products
When this top-earning PBS drug faced generic competition a year ago, a drop in price was expected but not the calamitous fall that actually occured
Two rare autoimmune diseases are costing Australians and the health system $1.2B every year, a new argenx backed report shows
A bumper start to Spring is on the cards with a long list of submissions recommended by the PBAC currently sitting in the last stage before listing occurs
Hundreds of pharma professionals have turned out for this year's much-anticipated NEXT Pharma Summit in Sydney for a sizzling hot conversation about the state of the local industry
The first commercial patient has received a living donor kidney transplant following treatment with a drug that was approved by the TGA three years ago and was finally added to National Health Reform Agreement last month
In a breath of fresh air for the Australian industry - hit hard by years of local workforce downsizing - this Big Pharma is on a hiring spree
Oceania GM, Michael Azrak, says the company is committed to being a trusted healthcare partner and working alongside like-minded organisations
